AbCellera Biologics Inc.
ABCL
Jodie situation report
AbCellera Biologics Inc.'s current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 17 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 5 directly disclosed connections are confirming.
- ABCL's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if ABCL's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind ABCL
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
BRKRBruker CorporationpartnerMay 11, 2026 ▾
“For example, we were engaged in a lawsuit with Bruker Cellular Analysis (“Bruker”) based upon our allegations of its infringement of our intellectual property rights that we settled in December 2025.”
LINELineage, Inc.investeeMay 11, 2026 ▾
“Through our acquisition of Lineage, we obtained patents and patent applications directed toward immune-repertoire sequencing.”
Depended on by
RLYBRallybio CorporationpartnerAug 7, 2025 ▾
“This multi-year, multi-target collaboration will combine AbCellera Biologics Inc.'s ("AbCellera's") antibody discovery engine with our clinical and commercial expertise in rare diseases to identify optimal clinical candidates with a goal of delivering therapi…”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 9 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
ABCL is currently a Follower in the organic co-movement group Healthcare & Credit Tech. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for ABCL; it is not active in the latest market snapshot.